Inizia
TopgOptions

NVAX Novavax Analyst Ratings

Long
Novavax, Inc. (NASDAQ:NVAX)  
TopgOptions  
NASDAQ:NVAX   Novavax, Inc.
Trend Analysis Technical Indicators Fundamental Analysis NVAX nvaxlong novavax Coronavirus (COVID-19) vaccine covidvaccine coronavirusstocks covid19stock
7
0
trendanalysis indicator fundamental nvax nvaxlong novavax coronavirus vaccine covidvaccine coronavirusstocks covid19stock
On 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00
On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00
On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00
On 5/12/2021 HC Wainwright brokerage Lowered the Price Target from $317.00 to $294.00

My personal price target is $240.

Looking forward to read your opinion.
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880

Idee correlate

TopgOptions
NVAX Novavax Vaccine approved! Buy Opportunity!
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.